CONSENSUS||RECOMMENDATIONS OF THE PORTUGUESE SOCIETY OF ANESTHESIOLOGY FOR THE SCHEDULE OF ELECTIVE PROCEDURES AFTER SARS-CoV-2 INFECTION IN THE NON-OBSTETRIC ADULT POPULATION IN PORTUGAL || MARCH 2022

Authors

DOI:

https://doi.org/10.25751/rspa.26918

Keywords:

COVID-19, SARS-CoV-2, anesthesia, anesthesiology, elective surgical procedures, diagnostic techniques and procedures, gastrointestinal endoscopy.

Abstract

The decision on the timing of an elective procedure after SARS-CoV-2 infection should be multidisciplinary, patient-centered. In assessing the risk/benefit of a postponement, the following should be considered: risk of progression of the underlying pathology; time elapsed after SARS-CoV-2 infection; infectious risk; severity of initial clinical presentation of COVID-19; persistence of symptoms; clinical status and frailty; vaccine status. This information must be discussed and included in the patient's free and informed consent (I C). If there is a clinical suspicion of COVID-19, all elective procedures must be rescheduled, until SARS-CoV-2 infection is excluded (I C). In the case of high-risk contacts, all elective procedures must be rescheduled, for a time later than 14 days after the date of the last exposure (IIa C). In the case of a history of SARS-CoV-2 infection: no elective procedure should be performed during the infectious period (IB) In non-priority elective procedures, it is recommended to postpone the surgery: 7 weeks, in individuals without a complete vaccination schedule and immunocompetent and who recovered from asymptomatic or mild COVID-19 (IIa B); 4 weeks, in individuals with a complete vaccination schedule and immunocompetent and who recovered from asymptomatic or mild COVID-19 (IIa C); Case by case, after 7 weeks, in immunosuppressed individuals or who recovered from moderate or severe or critical COVID-19 (I C); Subsequent postponements should be considered if symptoms persist (I B). In high-priority and high-priority elective procedures, the decision-making on the timing of the procedure must be taken analysing risk/benefit on a case-by-case basis (I C). Vaccination of patients proposed for elective surgery, who do not have a complete primary vaccination and booster vaccination, if eligible by the National Health Authority, should be encouraged. Preferably, the interval between the last inoculation and the procedure should be greater than 14 days (IB). Isolation before an elective procedure is not recommended. High-risk situations of contagion should be avoided (I B).

Downloads

Download data is not yet available.

References

WHO Coronavirus (COVID-19) Dashboard, WHO Coronavirus (COVID-19) Dashboard

Direção Geral de Saúde, Evolução do Covid-19 em Portugal

ASA and APSF Joint Statement on Elective Surgery/Procedures and Anesthesia for Patients after COVID-19 Infection

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update. A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England, Anaesthesia. https://doi.org/10.1111/anae.15699

Société Française d’Anesthésie et Réanimation. Positionnement de la SFAR sur le délai de report d’une intervention programmée après test de dépistage préoperatoire positif. 19/01/2022.

COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020;396(10243):27-38. Cross Ref doi: 10.1016/S0140-6736(20)31182-X

COVIDSurg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 2021;76(6):748-758. Cross Ref doi: 10.1111/anae.1545.

Deng JZ, et al. The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States. Ann Surg 2022;275(2):242-246. Cross Ref doi: 10.1097/SLA.0000000000005308

COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. The Lancet Oncology 2021;22(11):1507-17.Cross Ref https://doi.org/10.1016/S1470-2045(21)00493-9

DGS, Graus de Recomendação e Níveis de Evidência

Norma 013/2020, DGS, Retoma da Atividade Assistencial – Cirurgia Eletiva

Portaria n.º 153/2017 | DRE

Norma 012/2020, DGS, COVID-19: Exames Endoscópicos Digestivo

Norma 015/2020, DGS, COVID-19: Rastreio de Contactos

Norma 004/2020, DGS, Abordagem da Suspeita ou Confirmação de COVID-19

https://ourworldindata.org/covid-vaccinations?country=PRT

Relatório de Monitorização da Situação Epidemiológica da COVID-19

Nyberg T et al, Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022 Mar 16:S0140-6736(22)00462-7. doi: 10.1016/S0140-6736(22)00462-7. Epub ahead of print. PMID: 35305296.

Mannar et al., 2022, SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex, Science (2022), 10.1126/SCIENCE.ABN7760

COVIDSurg Collaborative. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. Br J Surg 2021;108(1):88-96. Cross Ref doi: 10.1093/bjs/znaa051.

Glasbey JC, et al, COVIDSurg Collaborative. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. J Clin Oncol. 2021 Jan 1;39(1):66-78. Cross Ref doi: 10.1200/JCO.20.01933.

Prasad NK, et al. COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity. Ann Surg 2022;275(1):31-36. Cross Ref doi: 10.1097/SLA.0000000000005176.

COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surgery 2021;108(9):1056–63. Cross ref doi: 10.1093/bjs/znab101.

Evidence-Check-COVID-19-vaccine-elective-surgery.pdf

https://www.sns24.gov.pt/guia/certificado-digital-covid-da-ue/certificado-de-vacinacao/

COVIDSurg Collaborative, GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia 2021; 76: 1454-64. Cross Ref https://doi.org/10.1111/anae.15560.

Published

2022-06-30

How to Cite

Paulino, A., Fortunato, M. ., Lança, F., Pires, I., Rego, L., Nave, P., Rodrigues, D. ., Taleço, T., Ana Correia Batista, A., Bernardino, A., Damas, A., Sá, C. ., Pedrosa, F., Marques da Costa, F. ., Portela, I., Lima de Morais, L. ., Mendes Cabral, L., Jorge Rodrigues, M., Luís, M., Antunes, P., Borges, R., Correia Conde, R., Santa Bárbara, R. ., & Chan Nogueira, Z. . (2022). CONSENSUS||RECOMMENDATIONS OF THE PORTUGUESE SOCIETY OF ANESTHESIOLOGY FOR THE SCHEDULE OF ELECTIVE PROCEDURES AFTER SARS-CoV-2 INFECTION IN THE NON-OBSTETRIC ADULT POPULATION IN PORTUGAL || MARCH 2022. Journal of the Portuguese Society of Anesthesiology, 31(2). https://doi.org/10.25751/rspa.26918

Most read articles by the same author(s)

1 2 3 > >>